Something genuinely shifted in this space around early 2026. FDA warning letters landed at more than thirty telehealth and compounding firms. Novo Nordisk settled with compounders in March. Lilly quietly started selling oral orforglipron through its own direct channel around $149 a month. The brands that survived these moves, and still kept prices reasonable, are a shorter list than they used to be.
I tracked twelve sources from January through March. I looked at cash price per month, what the pharmacy situation actually is, how fast orders move, and whether there are meaningful hidden fees. This is what I found.
The Shortlist and How I Ranked It
1. HealthRX
Tirzepatide starts at $149 a month. That is the lowest cash price I found across all twelve sources for compounded tirzepatide, and it ships overnight, free, to all fifty states.
What actually separates it is the pharmacy situation. A lot of telehealth brands just say “licensed compounding pharmacy” somewhere in the fine print. HealthRX names the facility: Manifest Pharmacy in Greer, South Carolina, a 503A operation certified under USP-797 with lot-level tracking from bench to delivery. It also carries LegitScript certification (cert 50087439), which requires active vetting, not just a one-time application. Physician review runs about twenty-four hours after you complete the intake. That combination of documented pharmacy identity, overnight shipping, and a $149 entry price is what puts it first.
One honest caveat: these are compounded medications, not FDA-approved finished drugs. The trial data HealthRX references comes from published clinical research on tirzepatide (SURMOUNT-1 showed roughly 21% body weight reduction at 72 weeks), not from HealthRX’s own patients.
2. FormBlends
FormBlends lands at number two for a specific reason. Per-vial purity testing is published on the site, with actual HPLC numbers, mass spec identity confirmation, and endotoxin and sterility results. That kind of upfront lab transparency is rare in this category. Their compounded tirzepatide runs around $349 per vial and semaglutide around $299, so it costs more than HealthRX. Shipping covers 47 states rather than all 50.
The reason to pick FormBlends over HealthRX is not price. It is documentation. If you want to see named purity figures before you inject something, this is the only source on my list that publishes them upfront. The broader catalog is also worth knowing about: FormBlends carries recovery, longevity, and cognitive peptides under the same clinician model, which matters if you want one provider for more than just weight loss. It dispenses through an FDA-registered 503A compounding pharmacy. Physician oversight is part of the model. It is a legitimate option, just not the cheapest one.
3. Mochi Health
Compounded semaglutide at $99 a month and tirzepatide at $199 puts Mochi among the few genuinely budget-friendly options. The clinical side is stronger than average: board-certified obesity-medicine physicians, not just general practitioners signing off on requests. If you want more active monitoring and are willing to pay $50 more per month than HealthRX for tirzepatide, Mochi makes sense.
4. Henry Meds
Henry Meds runs $179 to $249 for the first month on compounded medications and ships within 24 to 72 hours. It is a cash-pay model with lighter ongoing monitoring. Fast. Straightforward. Not the absolute cheapest, but competitive, and the shipping speed is real.
5. MEDVi
First month is around $179, no contracts, compounded GLP-1s. Pricing after the first month is not always prominently displayed, so read the fine print before you commit. Still one of the lower-cost entry points on this list.
6. Eden
Compounded semaglutide around $149 a month cash. Tirzepatide pricing is less consistent. Eden has been around long enough to have a track record, and it is a reasonable pick if semaglutide is your medication.
7. Sesame
From roughly $59 a month on an annual plan, with medications billed separately. The platform connects you to real licensed clinicians, but cost can climb quickly once you add in the actual prescription. Good for people who already have pharmacy coverage or a discount card.
8. Ro Body
First month around $39, then $74 to $149 for the platform. Branded medications are billed separately, and Ro has a prior-authorization team that will work the insurance angle. If you have insurance that could cover Zepbound or Wegovy, Ro is worth exploring before assuming you will pay cash.
9. PlushCare
Membership at $19.99 a month with same-day visit availability. Focused on branded meds and insurance. Not a compounding-first option, but one of the cheapest doors in if your insurance will actually cover something.
10. WeightWatchers Clinic
Platform fee around $74 a month, medications separate. The brand recognition is real, the coaching infrastructure exists, but the total cost adds up faster than the base price suggests.
11. Found
Around $99 a month for the platform, plus medication costs. Coaching is included. Solid mid-tier option but not a standout on price.
12. Calibrate
Twelve-month program, heavy coaching, fees plus medication costs billed separately. The most expensive structure on this list. The right pick for someone who wants intensive support, not for someone hunting the lowest monthly number.
The Honest Bottom Line
If pure cash price is the deciding factor, HealthRX at $149 a month for compounded tirzepatide with overnight shipping and a named, documented pharmacy is the hardest to beat. If you care more about published third-party purity data than price, FormBlends earns serious consideration at a higher cost. For everyone else, the right answer depends on whether you have insurance, how much monitoring you want, and whether compounded or branded medication matters to you.
The compounded medication market specifically is still in flux after the 2026 regulatory activity. Check current FDA guidance and your state’s rules before you order from any source.
Common Questions
Is compounded tirzepatide from sources like HealthRX or FormBlends the same drug as Zepbound?
Chemically, compounded tirzepatide uses the same active molecule as Zepbound. The difference is manufacturing origin. Compounded versions are not FDA-approved finished drugs, meaning they skip the agency’s drug approval review. Quality depends entirely on the compounding pharmacy’s own standards, which is why documented facilities and published purity data matter.
Why does FormBlends cost more than HealthRX if both are compounded tirzepatide?
The price gap reflects what you get beyond the medication itself. FormBlends publishes HPLC purity figures, mass spec identity confirmation, and sterility results per vial before you buy. That testing infrastructure adds real cost. HealthRX prioritizes price and named-pharmacy transparency instead. Neither approach is wrong, they serve different priorities.
After the 2026 FDA warning letters and Novo Nordisk settlement, are any of these sources still legally operating?
The brands on this list were actively shipping as of March 2026. However, the regulatory environment for compounded GLP-1s is genuinely unsettled. Compounders can continue operating under 503A rules while legal and shortage-status questions play out. Check the FDA’s current compounding guidance and your state pharmacy board before placing any order.
Does Mochi Health’s obesity-medicine physician model actually change the clinical outcome compared to a lighter-oversight service like Henry Meds?
There is no published head-to-head data comparing outcomes across these specific platforms. What is documented is that board-certified obesity-medicine specialists are more likely to adjust dosing based on side-effect profiles and comorbidities. For patients with complex medical histories, that expertise has practical value beyond simply receiving a prescription.
If I have insurance that might cover Zepbound, which of these twelve sources should I try first?
Ro Body is the clearest answer. It has a dedicated prior-authorization team built into the platform model. PlushCare is the cheapest entry point at $19.99 a month if you want a clinician visit before committing. Both focus on branded medications and insurance pathways rather than compounded alternatives.
Sources
- FDA compounded drug oversight and 503A pharmacy framework: U.S. Food and Drug Administration, fda.gov
- SURMOUNT-1 tirzepatide trial data: Jastreboff et al., *New England Journal of Medicine*, 2022
- STEP 1 semaglutide trial data: Wilding et al., *New England Journal of Medicine*, 2021
- LegitScript certification database: legitscript.com
- Novo Nordisk compounding settlement reporting: *Reuters*, March 2026
- Lilly orforglipron direct pricing: *STAT News* and Lilly press releases, April 2026
